Cognitive Decline in Non-demented PD
Cognitive Dysfunction in PD: Pathophysiology and Potential Treatments, a Pilot Study
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Listed as NCT01340885, this PHASE4 trial focuses on Parkinson's Disease and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 9 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jun 2018 — Aug 2020 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
- Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .